Ceridian HCM Stock Forecast, Price & News

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CDAY shares have increased by 33.5% and is now trading at $75.59.
View which stocks have been most impacted by COVID-19.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 2 sell ratings, 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Ceridian HCM.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc (NYSE:CDAY) released its earnings results on Wednesday, August, 5th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.14. Ceridian HCM had a return on equity of 1.74% and a net margin of 9.34%.
View Ceridian HCM's earnings history.

Ceridian HCM updated its third quarter 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $198-203 million, compared to the consensus revenue estimate of $204.84 million.

15 brokers have issued twelve-month target prices for Ceridian HCM's stock. Their forecasts range from $45.00 to $100.00. On average, they anticipate Ceridian HCM's stock price to reach $76.13 in the next year. This suggests a possible upside of 0.7% from the stock's current price.
View analysts' price targets for Ceridian HCM.

Ceridian HCM saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 9,490,000 shares, an increase of 22.0% from the June 15th total of 7,780,000 shares. Based on an average trading volume of 1,460,000 shares, the days-to-cover ratio is presently 6.5 days. Currently, 8.4% of the company's stock are short sold.
View Ceridian HCM's Short Interest.

Some companies that are related to Ceridian HCM include Veeva Systems (VEEV), Electronic Arts (EA), Docusign (DOCU), Twilio (TWLO), Synopsys (SNPS), Splunk (SPLK), Crowdstrike (CRWD), Cadence Design Systems (CDNS), ANSYS (ANSS), Datadog (DDOG), Okta (OKTA), Atlassian (TEAM), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Check Point Software Technologies (CHKP) and Coupa Software (COUP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Advanced Micro Devices (AMD), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Alteryx (AYX), Costco Wholesale (COST), ServiceNow (NOW), Paycom Software (PAYC) and Tesla (TSLA).

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities served as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Cannae Holdings Inc. (10.99%), Vanguard Group Inc. (7.39%), Thomas H Lee Partners LP (4.96%), Bamco Inc. NY (1.93%), FMR LLC (1.14%) and Bank of New York Mellon Corp (0.68%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Leagh Erin Turner, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc.
View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Thomas H Lee Partners LP, Cannae Holdings Inc., FMR LLC, Sei Investments Co., First Trust Advisors LP, Dragoneer Investment Group LLC, Principal Financial Group Inc., and Principal Financial Group Inc.. Company insiders that have sold Ceridian HCM company stock in the last year include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Leagh Erin Turner, Lisa M Sterling, Scott A Kitching, and Thomas H Lee Advisors, Llc.
View insider buying and selling activity for Ceridian HCM.

CDAY stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Bank of Nova Scotia, Point72 Asset Management L.P., Nuveen Asset Management LLC, Marshall Wace North America L.P., Goldman Sachs Group Inc., Oribel Capital Management LP, and Tudor Investment Corp Et Al.
View insider buying and selling activity for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $75.59.

Ceridian HCM has a market capitalization of $11.10 billion and generates $824.10 million in revenue each year. The company earns $78.70 million in net income (profit) each year or $0.26 on an earnings per share basis. Ceridian HCM employs 5,011 workers across the globe.

The official website for Ceridian HCM is www.ceridian.com.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]